← back to search

Emilie A. Chapeau

Novartis (Switzerland) · CH
Area of research
Oncology · Cell Biology
Research interest
Research interests include Insertional mutagenesis, Mdm2, Biology, Mutagenesis, Transposable element, and Essential thrombocythemia.
h-index
citations
73
works
2
NIH funding
primary concept
email

Recent publications

A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression
PLoS ONE 2019cited by 11position: firstdoi
Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf <sup>−/−</sup> mouse model
Proceedings of the National Academy of Sciences 2017cited by 62position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ralph Tiedt · Yale Cancer Center2 papers (2017–2019)Francesco Hofmann · Novartis (Switzerland)2 papers (2017–2019)Emeline Mandon · Novartis (Switzerland)2 papers (2017–2019)Vincent Romanet · Novartis (Switzerland)2 papers (2017–2019)Masato Murakami · Novartis (Switzerland)2 papers (2017–2019)Antoine de Weck · Centre for Human Genetics1 papers (2017–2017)Joseph Lehár · Fondation pour la Recherche Stratégique1 papers (2017–2017)Michael Rugaard Jensen · Novartis (Switzerland)1 papers (2017–2017)Moriko Ito · Novartis (Switzerland)1 papers (2019–2019)Matthias Mueller · University Hospital Heidelberg1 papers (2019–2019)Audrey Kauffmann · Novartis (Switzerland)1 papers (2017–2017)Agnieszka Gembarska · Novartis (Switzerland)1 papers (2017–2017) · 1 papers (2019–2019)Sabine Zumstein-Mecker · Novartis (Switzerland)1 papers (2019–2019)Rita Andraos-Rey · Novartis (Switzerland)1 papers (2019–2019)Stéphane Ferretti · Novartis (Switzerland)1 papers (2017–2017)Violetta Powajbo · Novartis (Switzerland)1 papers (2019–2019)Ernesto Bockamp · Johannes Gutenberg University Mainz1 papers (2019–2019)Pierre Moulin · University of Lausanne1 papers (2017–2017)Claire Estadieu · Novartis (Switzerland)1 papers (2017–2017)